Knockdown of miR-302/367 inhibits tumorigenesis via regulating the LATS2/YAP pathway, suggesting that modulation of LATS2/YAP is critical for prostate cancer metastasis and resistance and, hence, targeting of this signaling axis may be of a great cancer therapeutic potential [100]. The gene discussed is LATS2; the disease is prostate carcinoma.